Please assess the completion status of the following clinical trial:

Trial Title: Postpartum Weight Loss for Women at Elevated Cardiovascular Risk

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Age ≥18 years;~2. Delivered a baby at HUP or PAH within 3-12 months prior to study start;~3. BMI ≥ 27 kg/m2~4. Diagnosis of one of the following medical conditions: chronic hypertension, gestational hypertension, preeclampsia, eclampsia, gestational diabetes, or diabetes mellitus (type 1 or 2) based on diagnosis codes in the EMR~5. Has online access through smartphone or computer and has email address~6. Ability to read and provide informed consent to participate in the study~Exclusion Criteria:~1. Delivered prior to 32 weeks gestation in the EMR~2. Documentation of fetal demise or neonatal demise in the EMR~3. Currently pregnant or planning to get pregnant within the next 5 months~4. Does not speak English~5. Answers yes to any of the following questions:~   * Are you currently participating in any other weight loss or physical activity studies?~  * Do you have any medical conditions or other reasons why you could not participate in a 16-week weight loss or physical activity program?~6. Participants will be excluded after completing the run-in period if they do not complete the daily food log or their baseline BMI is \< 27 kg/m2

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Online Behavioral Weight Loss (Type: ACTIVE_COMPARATOR): Participants will attend a virtual introduction to weight loss session and be enrolled in a 16-week online behavioral weight loss program. Participants will complete a virtual weigh-in at the start and end of the study.
- Usual Care (Type: ACTIVE_COMPARATOR): Participants will complete a virtual weigh-in at the start and end of the study. No additional intervention will be provided.

Based on this trial design, predict the completion outcome and termination type (if applicable).